Vasomedical

Vasomedical

About the Vasomedical Group

Vasomedical, Inc. is primarily engaged in designing, manufacturing, marketing and supporting EECP® external counterpulsation systems based on the Company's proprietary... more »
Vasomedical, Inc. is primarily engaged in designing, manufacturing, marketing and supporting EECP® external counterpulsation systems based on the Company's proprietary technology. EECP® therapy is a non-invasive, outpatient therapy for the treatment of diseases of the cardiovascular system currently indicated for use in cases of angina, cardiogenic shock, acute myocardial infarction and congestive heart failure. The therapy serves to increase circulation in areas of the heart with less than adequate blood supply and may restore systemic vascular function. The Company provides hospitals, clinics and private practices with EECP® equipment, treatment guidance and a staff training and maintenance program designed to provide optimal patient outcomes. EECP® is a registered trademark for Vasomedical's enhanced external counterpulsation system. Through its agreement with GE Healthcare, the Company is also engaged as an exclusive sales representative for certain GE Healthcare products. VasoHealthcare™, a wholly owned subsidiary of Vasomedical Inc. is a professional sales representation company offering vendors an alternative third party sales channel. Additional information is available on the Company's website at www.vasomedical.com. « less

Have something to say?

Join LinkedIn for free to participate in the conversation. When you join, you can comment and post your own discussions.

Join LinkedIn

Most Popular Discussions

Paul P.

Paul

NEW! Angina diary in the Patients section: Users may record angina attacks and email weekly summary to physician for evaluation. A useful tool to assess the effect of EECP therapy. NEW! Newsletter in Physicians section: Vasomedical EECP newsletters in PDF format now can be read and downloaded directly from within the app.

posted March 16, 2011

Carl D. 6 months ago • Edit • Great Job Paul! You truly are our "connection man." »
See more »
Carl D.
Paul P.

Paul

Vasomedical, Inc., a world leader in the noninvasive treatment of cardiovascular diseases, today reported financial results for the three months...

posted April 15, 2011

Edit • »
See more »
Paul P.

Paul

WESTBURY, N.Y.--(BUSINESS WIRE)--Vasomedical, Inc. today announced its receipt of U.S. FDA 510(k) clearance to market its Vasomedical-BIOX™ Model 2302 Combined 12-Channel ECG Holter/ Blood Pressure Monitor and Model 1804 ABP Monitor

posted 10 months ago

Edit • »
See more »
Paul P.

Paul

WESTBURY, N.Y.--(BUSINESS WIRE)--Vasomedical, Inc. today announced its receipt of the U.S. FDA 510(k) clearance to market its Vasomedical-BIOX™ Model 1303 3-channel ECG Holter Monitor and Model 1304 12-channel ECG Holter Monitor.

posted 10 months ago

Edit • »
See more »
Paul P.

Paul

Vasomedical Announces Introduction into the Korean Market

posted 10 months ago

Edit • »
See more »
Paul P.

Paul

http://bit.ly/nRHln8

http://www.vasomedical.com/vasonews_8_3_11.php

posted 9 months ago

Edit • »
See more »
Paul P.

Paul

Vasomedical Announces Agreement to Acquire Two China-based Companies

posted 9 months ago

Renee L. 9 months ago • Edit • Renee likes this. »
See more »
Paul P.

Paul

Vasomedical Reports Financial Results for the Year Ended May, 31, 2011

Vasomedical, Inc.today reported financial results for the fiscal year ended May 31, 2011. For the fiscal year 2011, which ended May 31, 2011, the...

posted 9 months ago

Edit • »
See more »
Paul P.

Paul

Vasomedical Completes Acquisition of Life Enhancement Technology and Biox Instruments

posted 8 months ago

Edit • »
See more »
Paul P.

Paul

Vasomedical Announces Corporate Restructure and Appointment of New Chief Financial Officer

Vasomedical Announces Corporate Restructure and Appointment of New Chief Financial...

posted 8 months ago

Edit • »
See more »
Paul P.

Paul

William Lawson, MD Presents on EECP® Therapy at Medical Grand Rounds at Bridgeport Hospital

posted 7 months ago

Edit • »
See more »
Paul P.

Paul

Vasomedical Reports Financial Results for the Quarter Ended August 31, 2011

Vasomedical, Inc. today reported financial results for the three months ended August 31, 2011. For the first quarter of fiscal 2012, the Company...

posted 7 months ago

Edit • »
See more »
Paul P.

Paul

Dr. Debra Braverman speaks out on EECP® therapy on KTSA-AM in San Antonio, TX

News Release vasomedical.com

Dr. Debra Braverman speaks out on EECP® therapy on KTSA-AM in San Antonio, TX WESTBURY, N.Y. November 3, 2011 – Dr. Debra Braverman, author of Heal Your Heart with EECP® Therapy was interviewed about EECP® therapy today on...

posted 6 months ago

Edit • »
See more »
Paul P.

Paul

Dr. Clayton Bredlau Talks About EECP® Therapy on WWSB-TV, Channel 7, “ABC 7 News at Noon” in Sarasota,...

News Release vasomedical.com

Dr. Clayton Bredlau Talks About EECP® Therapy on WWSB-TV, Channel 7, “ABC 7 News at Noon” in Sarasota, Florida WESTBURY, N.Y. November 10, 2011 – Dr. Clayton Bredlau, of The Heart & Vascular Center in Sarasota, Florida appeared...

posted 6 months ago

Edit • »
See more »

About this Group

  • Created: March 4, 2011
  • Type: Corporate Group
  • Members: 8
Ad

Group Statistics

CHECK OUT INSIGHTFUL STATISTICS ON THIS GROUP

  1. Director
  2. Manager
  3. Entry
MEMBERS
3,759
View Group Statistics »